因此，高血压的基因治疗已逐渐成为高血压治疗研究的重点。实践证明，基因治

Therefore, gene therapy of hypertension has become the focus of treatment of hypertension research. Practice has proved that gene therapy can not only reduce blood pressure steady, and can control high blood pressure fundamentally, and can effectively control the family genetic predisposition. This indicates that the desired effect, the gene therapy of high blood pressure is no longer a utopian. Although the research is not yet mature, but certainly a very attractive prospect. <br>With in-depth study of the pathogenesis of hypertension and blood pressure regulation mechanism, people are still actively looking for the ideal antihypertensive drugs, blood pressure will no doubt find more new targets.

Therefore, gene therapy of hypertension has gradually become the focus of hypertension treatment research. It has been proved that gene therapy can not only reduce blood pressure steadily, but also control the occurrence of hypertension, and effectively control the genetic tendency of family. This ideal effect suggests that gene therapy for hypertension is no longer utopian. Although the research is not yet mature, it certainly has a very attractive prospect.<br>With the in-depth study of hypertension pathogenesis and blood pressure regulation mechanism, people are still actively looking for the ideal antihypertensive medicine, will undoubtedly find more new targets for low blood pressure.

Therefore, gene therapy of hypertension has gradually become the focus of hypertension treatment research. It has been proved that gene therapy can not only reduce blood pressure continuously and stably, but also fundamentally control the occurrence of hypertension, and effectively control family genetic tendency. This ideal effect shows that gene therapy for hypertension is no longer Utopian. Although the relevant research is not mature at present, there is undoubtedly a very attractive prospect.<br>With the in-depth study of the pathogenesis and blood pressure regulation mechanism of hypertension, people are still actively looking for ideal antihypertensive drugs, which will undoubtedly find more new targets for hypotension.